Medicinal Cannabis for Children: Evidence and Recommendations

Join Associate Professor Lauren Kelly as we delve into the complex and often controversial topic of medical cannabis for children.

About this webinar

In recent years, there has been growing interest and debate surrounding the use of cannabis-derived products in paediatric medicine. Parents, caregivers, healthcare professionals, and policymakers are seeking evidence-based guidance on the safety, efficacy, and appropriate use of medical cannabis for children. This webinar offers a comprehensive overview of the current evidence and recommendations concerning medical cannabis use in paediatric populations. Our expert speaker will draw upon the latest research to delve into safety considerations, risk mitigation strategies, and the exploration of potential therapeutic benefits across various paediatric conditions, including epilepsy, autism spectrum disorder, cancer-related symptoms, and beyond.

Learning Outcomes

Identify potential therapeutic benefits for paediatric conditions like epilepsy, autism spectrum disorder, and cancer-related symptoms
Evaluate the effectiveness of safety protocols and risk mitigation strategies in minimising the potential risks of medical cannabis use in paediatric patients
Assess the evidence supporting the safety, effectiveness, and practical use of medical cannabis in paediatric medicine

About the speaker

Dr Lauren Kelly is an Associate Professor in pharmacology and therapeutics at the University of Manitoba. She is a scientist at the Children’s Hospital Research Institute of Manitoba, certified clinical research professional and a clinical trialist at the George and Fay Yee Centre for Healthcare Innovation.

She received a PhD in pharmacology and toxicology from the University of Western Ontario and completed two Post-doctoral Fellowships at the Hospital for Sick Children and at Mount Sinai Hospital in Toronto.

Dr Kelly is the scientific director of the Canadian Collaborative for Childhood Cannabinoid Therapeutics, a pan-Canadian research platform that studies the safety of cannabis products used for medical purposes in the paediatric population.

Her program involves partnering with parents, doctors, nurses, pharmacists and policy makers to design and conduct a variety of clinical research studies.

On-demand Webinar

Subscribe to our Free Plan and gain access to this on-demand webinar plus four more, at no cost.

Webinar details

Claim 1 CPD hour

1 hour of recorded content

Statement of Attendance

Our Sponsors

Claim 1 CPD Hour

Medihuanna is a CPD approved education provider, and this activity has been approved by the RACGP (Activity ID: 812391). Upon completing this activity, you will be eligible to claim CPD hours. The activity will include the following CPD allocation which will be uploaded to the RACGP dashboard.